To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparison of efficacy between Artz and Durolane HAs at 18 and 26 weeks in treatment of knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2019

Comparison of efficacy between Artz and Durolane HAs at 18 and 26 weeks in treatment of knee OA

Vol: 8| Issue: 7| Number:37| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz

Arthritis Res Ther. 2015 Mar 10;17:51. doi: 10.1186/s13075-015-0557-x

Contributing Authors:
J Zhang J Lin X Zhang Z Zhu T Sun J Jones K Zhang H Zhang A Guo B Shan S Yan RG Steen

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

349 patients with knee osteoarthritis were randomized to either one intraarticular injection of Durolane hyaluronic acid followed by four weekly subcutaneous sham injections, or five weekly intraarticular injections of Artz hyaluronic acid. Patients were assessed for primarily for response on the Western Ontario and McMaster Universities Osteoarthritis Index to determine if Durolane was noninferio...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.